Opportunity Information: Apply for HT942526OCRPPA
The Department of the Army, through the U.S. Army Medical Research Acquisition Activity (USAMRAA), is offering the DoD Ovarian Cancer Research Program (OCRP) Pilot Award (Funding Opportunity Number: HT942526OCRPPA). This grant mechanism is designed to push the ovarian cancer field forward by backing early-stage, high-impact ideas that challenge existing assumptions or take a fresh approach to longstanding problems. The central goal is to support studies that expand or reshape current thinking in ovarian cancer and open credible paths toward critical discoveries or major advancements, rather than simply extending established lines of work.
A defining expectation of this award is innovation. The solicitation makes it clear that strong science alone is not enough if the project does not bring something genuinely new to the table. Proposals that are methodologically rigorous but incremental or routine are not considered a good fit for this mechanism. In practical terms, applicants should frame a clear, novel concept, theory, tool, strategy, or line of inquiry and explain why it could materially change how ovarian cancer is understood, studied, prevented, detected, or treated.
The Pilot Award is structured to be accessible to ideas that may not yet have extensive supporting results. Preliminary data are not required, which lowers the barrier for exploratory concepts, new directions, and first tests of unconventional hypotheses. At the same time, preliminary data are permitted, so applicants who do have early supportive findings can include them if doing so strengthens feasibility or clarifies the rationale, as long as the emphasis remains on innovation and potential impact.
This opportunity uses a blinded pre-application process. Before a full application is invited, pre-applications go through a blinded screening in which reviewers are not supposed to know who the principal investigator is or where the work is being done. Because of that, the pre-application must be prepared without any identifying details for the PI, collaborators, or institutions. That includes avoiding names, institutional references, and other contextual clues that could reveal identity. The intent is to keep the early screening focused on the idea itself, its novelty, and its promise for moving the field forward.
Administratively, this is a discretionary grant in the Science and Technology / Research and Development category (CFDA 12.420). Eligibility is listed as unrestricted, meaning the program is broadly open to applicants rather than limited to a narrow set of institution types. The funding opportunity was created on May 4, 2026, and the original closing date is October 1, 2026. The solicitation indicates an anticipated 13 awards. An award ceiling is not specified in the provided notice, so applicants would need to consult the full announcement or program materials for budget limits, performance period details, and any cost constraints or requirements.
Overall, this Pilot Award is best viewed as a catalyst for bold ovarian cancer research ideas, especially those that could change the trajectory of the field if the initial concept proves out. Applicants will be most competitive when they present a clearly differentiated innovation, explain how it departs from or improves on current approaches, and make a compelling case that the work could unlock meaningful advances even at an early, pilot stage.Apply for HT942526OCRPPA
- The Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoW, Ovarian Cancer, Pilot Award" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
- This funding opportunity was created on 2026-05-04.
- Applicants must submit their applications by 2026-10-01. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 13 candidate(s).
- Eligible applicants include: Unrestricted.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs): DoD Ovarian Cancer Research Program (OCRP) Pilot Award
What is this funding opportunity?
This opportunity is the Department of Defense (DoD) Ovarian Cancer Research Program (OCRP) Pilot Award, offered by the Department of the Army through the U.S. Army Medical Research Acquisition Activity (USAMRAA). The Funding Opportunity Number is HT942526OCRPPA.
What is the main purpose of the OCRP Pilot Award?
The Pilot Award is intended to push the ovarian cancer research field forward by supporting early-stage, high-impact ideas. The emphasis is on projects that expand or reshape current thinking and open credible paths toward critical discoveries or major advancements, rather than extending established lines of work.
What kinds of projects does this award prioritize?
The award prioritizes bold, innovative studies in ovarian cancer that challenge existing assumptions or take fresh approaches to longstanding problems. Applicants are expected to present a novel concept, theory, tool, strategy, or line of inquiry with the potential to materially change how ovarian cancer is understood, studied, prevented, detected, or treated.
How important is innovation for this mechanism?
Innovation is a defining expectation. The solicitation indicates that strong science alone is not sufficient if a project is incremental, routine, or primarily an extension of existing work. Proposals should clearly demonstrate what is genuinely new and why it matters for advancing the field.
Are incremental or routine projects a good fit?
No. Methodologically rigorous projects that are incremental or routine are described as not being a good fit for this mechanism. The program is focused on ideas that could change the trajectory of ovarian cancer research.
Is preliminary data required?
No. Preliminary data are not required, which is intended to lower the barrier for exploratory concepts, new directions, and first tests of unconventional hypotheses.
Can preliminary data be included anyway?
Yes. Preliminary data are permitted and may be included if they strengthen feasibility or clarify the rationale. However, the project should still be framed around innovation and potential impact rather than relying on extensive supporting results.
What is the application process format?
This opportunity uses a blinded pre-application process. Pre-applications are screened first, and only selected applicants are invited to submit a full application.
What does "blinded pre-application" mean here?
In the pre-application stage, reviewers are not supposed to know who the principal investigator (PI) is or where the work is being performed. The intent is for early screening to focus on the idea itself, including its novelty and promise for moving the field forward.
What information must be excluded from the pre-application to maintain blinding?
The pre-application must be prepared without identifying details for the PI, collaborators, or institutions. This includes names, institutional references, and other contextual clues that could reveal identity.
Who is eligible to apply?
Eligibility is listed as unrestricted, meaning the program is broadly open to applicants rather than limited to a narrow set of institution types.
Which agency and program category does this fall under?
Administratively, it is a discretionary grant in the Science and Technology / Research and Development category, with CFDA 12.420.
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is HT942526OCRPPA.
When was this opportunity created and when does it close?
The opportunity was created on May 4, 2026, and the original closing date is October 1, 2026.
How many awards does the program expect to make?
The solicitation indicates an anticipated 13 awards.
Is there a stated maximum award amount (award ceiling)?
An award ceiling is not specified in the provided notice. Applicants would need to consult the full announcement or program materials for budget limits, performance period details, and any cost constraints or requirements.
What should applicants emphasize to be competitive?
Competitive applications should present a clearly differentiated innovation, explain how it departs from or improves on current approaches, and make a compelling case that the work could unlock meaningful advances even at an early, pilot stage.
What is the overall "best use" of the Pilot Award, based on the description?
It is best viewed as a catalyst for bold ovarian cancer research ideas, especially those that could change the trajectory of the field if the initial concept proves out.
Browse more opportunities from the same category: Science and Technology and other Research and Development
Previous opportunity: Tree Island Wildlife Habitat Assessment for Water Conservation Area 3 and Everglades National Park, Florida
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for HT942526OCRPPA
Applicants also applied for:
Applicants who have applied for this opportunity (HT942526OCRPPA) also looked into and applied for these:
| Funding Opportunity |
|---|
| DoW Breast Cancer, Era of Hope Scholar Award Apply for HT942526BCRPEOHS Funding Number: HT942526BCRPEOHS Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Breast Cancer, Transformative Breast Cancer Consortium Development Award Apply for HT942526BCRPTBCCDA Funding Number: HT942526BCRPTBCCDA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Breast Cancer, Transformative Breast Cancer Consortium Award Apply for HT942526BCRPTBCCA Funding Number: HT942526BCRPTBCCA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Spinal Cord Injury, Translational Research Award Apply for HT942526SCIRPTRA Funding Number: HT942526SCIRPTRA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Hearing Restoration Focused Research Award Apply for HT942526HRRPFRA Funding Number: HT942526HRRPFRA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Multiple Sclerosis Exploration-Hypothesis Development Award Apply for HT942526MSRPEHDA Funding Number: HT942526MSRPEHDA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Multiple Sclerosis Investigator-Initiated Research Award Apply for HT942526MSRPIIRA Funding Number: HT942526MSRPIIRA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Multiple Sclerosis Early Investigator Research Award Apply for HT942526MSRPEIRA Funding Number: HT942526MSRPEIRA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Spinal Cord Injury, Clinical Translation Research Award Apply for HT942526SCIRPCTRA Funding Number: HT942526SCIRPCTRA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Spinal Cord Injury, Clinical Trial Award Apply for HT942526SCIRPCTA Funding Number: HT942526SCIRPCTA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Multiple Sclerosis Clinical Trial Award Apply for HT942526MSRPCTA Funding Number: HT942526MSRPCTA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Spinal Cord Injury, Investigator-Initiated Research Award Apply for HT942526SCIRPIIRA Funding Number: HT942526SCIRPIIRA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Lupus, Transformative Vision Award Apply for HT942526LRPTVA Funding Number: HT942526LRPTVA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Lupus, Idea Award Apply for HT942526LRPIA Funding Number: HT942526LRPIA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Lupus, Transformative Vision Development Award Apply for HT942526LRPTVDA Funding Number: HT942526LRPTVDA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Lupus, Impact Award Apply for HT942526LRPIPA Funding Number: HT942526LRPIPA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Lung Cancer Patient-Centered Outcomes and Survivorship Award Apply for HT942526LCRPPCOSA Funding Number: HT942526LCRPPCOSA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Lung Cancer Idea Development Award Apply for HT942526LCRPIDA Funding Number: HT942526LCRPIDA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Tuberous Sclerosis Complex, Idea Development Award Apply for HT942526TSCRPIDA Funding Number: HT942526TSCRPIDA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Tuberous Sclerosis Complex, Clinical Translational Research Award Apply for HT942526TSCRPCTRA Funding Number: HT942526TSCRPCTRA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "HT942526OCRPPA", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.